The abstract is read at the publisher; the summary is JClub's.
In corticosteroid-free adults with asthma, 11/46 (24%) still show persistent indirect airway hyperresponsiveness to mannitol after six weeks of 1600 μg budesonide daily.
- Why it matters: Indirect AHR usually improves with inhaled corticosteroids, so persistence after high-dose treatment may signal incomplete suppression of airway inflammation.
- What they did: RECONSTRUCT post-hoc analysis stratified patients as responders (PD15 ≥635 mg) or incomplete responders (PD15 <635 mg) using bronchoscopy and T2 biomarkers before and after six weeks of high-dose ICS.
- The result: Incomplete responders had higher baseline T2 biomarkers and airway chymase-positive mast cell density, and after treatment they still had higher blood and sputum eosinophils, with smaller reductions in blood eosinophils.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.